Fingerprint
Dive into the research topics of 'Expected monetary impact of oncotype DX score-concordant systemic breast cancer therapy based on the TAILORx trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Expected monetary impact of oncotype DX score-concordant systemic breast cancer therapy based on the TAILORx trial
Angela Mariotto, Jinani Jayasekerea, Valentina Petkov, Clyde B. Schechter, Lindsey Enewold, Kathy J. Helzlsouer, Eric J. Feuer, Jeanne S. Mandelblatt
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations